ROTEM in Patients With Placenta Previa
- Conditions
- Placenta AccretaPlacenta IncretaPlacenta PreviaPlacenta Percreta
- Interventions
- Diagnostic Test: ROTEM
- Registration Number
- NCT04213755
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
The rotational thromboelastogram (ROTEM) test can be performed on patients with placenta previa/accreta/increta/percreta who have a high likelihood of massive bleeding, and the predictors can be identified by comparing the patients who actually show massive bleeding with those who do not.
Applying these predictive factors to pregnant women undergoing cesarean section after diagnosis of placenta previa/accreta/increta/percreta, it will be advantageous for the perioperative management because it is possible to select pregnant women with a factor of massive bleeding.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 100
- Cesarean section under spinal anesthesia
- Placenta previa
- Placenta accreta
- Placenta increta
- Placenta percreta
- Coagulopathy
- Medication with antiplatelets or anticoagulants
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patients with risks of intraoperative massive bleeding ROTEM patients with risks of intraoperative massive bleeding
- Primary Outcome Measures
Name Time Method Change of INTEM 10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation intrinsic pathway component
Blood loss 1 min after finishing an operation Volume of intraoperative blood loss
Change of EXTEM 10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation extrinsic pathway component
Change of APTEM 10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation fibrinolytic component
Change of FIBTEM 10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation the level of fibrinogen
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National University Bundang Hospital
🇰🇷Seongnam, Gyeonggi, Korea, Republic of